0000899243-21-028253.txt : 20210713
0000899243-21-028253.hdr.sgml : 20210713
20210713200023
ACCESSION NUMBER: 0000899243-21-028253
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210712
FILED AS OF DATE: 20210713
DATE AS OF CHANGE: 20210713
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tehrani Ali
CENTRAL INDEX KEY: 0001761853
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38068
FILM NUMBER: 211089060
MAIL ADDRESS:
STREET 1: 1385 WEST 8TH AVENUE
STREET 2: SUITE 540
CITY: VANCOUVER
STATE: A1
ZIP: V6H3V9
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zymeworks Inc.
CENTRAL INDEX KEY: 0001403752
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 540-1385 WEST 8TH AVENUE
CITY: Vancouver
STATE: A1
ZIP: V6H 3V9
BUSINESS PHONE: (604) 678-1388
MAIL ADDRESS:
STREET 1: 540-1385 WEST 8TH AVENUE
CITY: Vancouver
STATE: A1
ZIP: V6H 3V9
FORMER COMPANY:
FORMER CONFORMED NAME: Zymeworks Inc
DATE OF NAME CHANGE: 20070620
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-07-12
0
0001403752
Zymeworks Inc.
ZYME
0001761853
Tehrani Ali
C/O ZYMEWORKS INC.
1385 WEST 8TH AVENUE, SUITE 540
VANCOUVER
A1
V6H 3V9
BRITISH COLUMBIA, CANADA
1
1
0
0
Chief Executive Officer
Common Shares
2021-07-12
4
M
0
12669
4.3062
A
272994
D
Common Shares
2021-07-12
4
S
0
12669
36.1224
D
260325
D
Common Shares
55511
I
Held by spouse
Stock Option (Right to Buy)
4.3062
2021-07-12
4
M
0
12669
0.00
D
2013-01-01
2022-01-01
Common Shares
12669
44991
D
Pursuant to a 10b5-1 plan entered into May 13, 2021.
The exercise price of the stock option is CAD5.37. The U.S. dollar equivalent of the exercise price is $4.3062 using the Bank of Canada exchange rate for July 12, 2021 (CAD1.00 = $0.8019).
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.0649 to $36.5902, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 12, 2021 at each separate price.
Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date of January 1, 2012 and (ii) remainder of underlying shares in 36 equal monthly installments on the last day of month following first anniversary of grant date.
/s/ Daniel Dex, Attorney-in-Fact
2021-07-13